Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Japan Exchange +8 Other | 3,469,807 | 4,192 JPY | Stock | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Deutsche Boerse AG | 340 | 24.88 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0RN3 | London S.E. | 0 | 37.59 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Börse Stuttgart | - | 24.35 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | BOERSE MUENCHEN | 112 | 24.77 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKPHF | OTC Markets | 2,037 | 26.86 USD | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKD | Wiener Boerse | - | 24.82 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Fukuoka Stock Exchange | 0 | 4,080 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 4502 | Sapporo S.E. | 0 | 4,300 JPY | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAKP34 | Sao Paulo | 413 | 69.86 BRL | Stock | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK | Nyse +5 Other | 1,258,872 | 13.36 USD | Stock | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TAK N | Mexican S.E. | 4,851 | 240.5 MXN | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Deutsche Boerse AG | - | 12.1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | Börse Stuttgart | - | 12.1 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | TKDA | BOERSE MUENCHEN | - | 12.3 EUR | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | 0A87 | London S.E. | 843 | 13.53 USD | ||
TAKEDA IP HOLDINGS CO.,LTD. | 7875 | Japan Exchange | 8,160 | 852 JPY | Stock | |
TAKEDA MACHINERY CO., LTD. | 6150 | Japan Exchange | 7,113 | 3,340 JPY | Stock | |
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Deutsche Boerse AG | - | 95.93 % | Bond | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 91.72 % | Bond | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 83.96 % | Bond | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 88.2 % | Bond | ||
TAKEDA PHARMACEUTICAL COMPANY LIMITED | BOERSE MUENCHEN | - | 96.18 % | Bond |
News (16)
Companies (6)
Takeda Pharmaceutical Company Limited specializes in the development, manufacturing and marketing of pharmaceutical products especially for metabolic and cardiovascular diseases, cancers and central nervous systems troubles. The activity is organized arou ...
Takeda iP Holdings Co Ltd, formerly Takeda Printing Co Ltd, is mainly engaged in the printing business. The Company operates in two business segments. The Printing segment has two businesses. The printing business is engaged in planning and production of ...
Affymax, Inc. is a biopharmaceutical company. The Companyâs product OMONTYS (peginesatide) is for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent ...
TAKEDA MACHINERY CO., LTD. is a Japan-based company mainly engaged in the manufacture and sale of shaped steel processing machines and circular saw machines for the processing of steel frames, steel materials, sheet metals and others. The Machine Tools Re ...
Ligand Pharmaceuticals Incorporated is a biopharmaceutical company enabling scientific advancement through supporting the clinical development of medicines. The Company does this by providing financing, licensing its technologies or both. Its Captisol pla ...
DRI Healthcare Trust is a Canada-based company, which is engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institu ...
Insiders
Mr. Norimasa Takeda is a Chief Accounting Officer & Corporate Controller at Takeda Pharmaceutical Co., Ltd.
Currently, Norimasa Kitazawa is President & Representative Director at Pigeon Corp.
Presently, Norimasa Sato occupies the position of Chief Financial Officer & Senior Managing Director at Welcia Holdings Co., Ltd. and Auditor of Welcia Kaigo Service Co., Ltd. Mr. Sato is also on the board of Welcia Yakkyoku Co., Ltd. In his past career he held the position of Corporate Auditor at Ouen Kazoku Co., Ltd.
Currently, Chikashi Takeda occupies the position of Chief Financial Officer at Olympus Corp. In the past he occupied the position of Senior Executive Officer & Head-Finance at Astellas Pharma, Inc.
Currently, Kazunori Takeda holds the position of Executive Vice President & President-Commerce at Rakuten, Inc. Mr. Takeda is also on the board of Gurunavi, Inc., Rakuten General Insurance Co., Ltd., Fusion Communications Corp. and Rakuten Vissel Kobe, Inc. He received an MBA from Harvard Business School.
Kazuhiko Takeda is on the board of Sony (China) Co., Ltd. and Executive Officer at Sony Corp.
Norimasa Maida formerly worked at Toyo Seikan Group Holdings Ltd., as Director & Managing Executive Officer from 2015 to 2016 and Toyo Kohan Co., Ltd., as Executive Officer & GM-Chemical Products Planning from 2011 to 2016.
Norimasa Shinya is currently working as a Senior Analyst at Mizuho Securities Co., Ltd.
(Broker).
Norimasa Kunimoto currently works at Terumo Europe NV (Belgium), as Chief Executive Officer from 2018, Terumo France SAS, as Chairman, Terumo (Deutschland) GmbH, as Co-Managing Director, and Terumo UK Ltd., as Director.
Norimasa Yamamizu is currently working as the Director, Executive Officer & GM-Foodstuffs at Shinyei Kaisha.
Norimasa Tanabe is currently a Partner at Ant Capital Partners Co., Ltd.
since 2009.
He previously worked as a Director at Kagayaku Cosmetics, Inc.
Mr. Norimasa Ogawa is a Research Analyst at Daiwa Securities Capital Markets Co. Ltd.
Norimasa Komatsu is currently the President & Representative Director at Genesis Technology, Inc. since 1997.
Prior to this, he worked at Kobe Steel, Ltd.
as a Principal from 1974 to 1998.
Norimasa Kuroda is currently the Chairman of Shouohkai Foundation and a Non-Executive Director at JTB Corp.
He previously held positions as Chairman at Mizuho Trust & Banking Co., Ltd., Independent Outside Director at Tokyo Tatemono Co., Ltd., Outside Director at Sompo Japan Insurance, Inc., and Deputy President at Mizuho Bank Ltd.
Norimasa Takeshima held the position of President & Representative Director at Daido Sittipol Co. Ltd.
and Executive Officer at Daido Kogyo Co., Ltd.
Norimasa Okubo currently works as an Executive Officer at Kokubu Group Corp.
Norimasa Fujii currently works at Fuji Foods, Inc. as the Head-Kanagawa Plant.
Norimasa Sato currently works at Takamisawa Co., Ltd., as Senior Managing Director.
Norimasa Yoshida is an Independent Outside Director at Benefit Japan Co., Ltd.
since 2016.
He previously held positions as Chairman at Senshu Ikeda Holdings, Inc. and The Senshu Ikeda Bank Ltd., and as President at Senshu Bank Ltd.
Norimasa Somiya held positions as a Director at Osaka Steel Co., Ltd., an Independent Director at Chubu Steel Plate Co., Ltd., and a Manager at Nagoya Steel Plant for Nippon Steel Corp.
Norimasa Tsunemi has a current job as the Director, Head-Accounting & Finance at Ensuiko Sugar Refining Co., Ltd.
Norimasa Sakata has worked as an Auditor at Mitani Sangyo Co., Ltd.
since 2016.
Norimasa Nosaka has a current job as Co-Managing Director at BBS Motorsport GmbH.
Norimasa Kurata currently works at Union Tool Co., as Executive Officer & General Manager-Administration.
Toru Takeda is currently working as an Auditor at Seikagaku Corp.
He started this position in 2016.
Previously, he worked as an Auditor at Mizuho Trust & Banking Co., Ltd.
Osamu Takeda currently works at Kobundo Co., Ltd., as Senior Managing Director.
Yoshinobu Takeda is currently the President & Representative Director at Data Applications Co., Ltd.
since 2015.
He is also an Outside Director at Cyberlinks Co., Ltd.
Mr. Takeda previously worked as a Director at Holon Technology KK and Kagoshima Data Applications KK.
Yasuhumi Takeda is associated with Milbon Co., Ltd.
since 1981.
He currently holds the position of Director & General Manager-Development, which he started in 2014.
Tsuneharu Takeda is an Outside Director at Mandarin Oriental Tokyo Co., Ltd.
since 2013.
He previously served as an Independent Outside Director at Kureha Corp.
and as an Outside Director at KCJ Group, Inc.
Keiji Takeda currently works at IRISO Electronics Co., Ltd., as Director, EVP & General Manager-Manufacturing from 2023.
Yoshisada Takeda worked as the Director and Head of Sales & Real Estate at Takenaka Corp..
Mr. Takeda attended Keio University where he received his undergraduate degree in 1972.
Shoichi Takeda is currently the President & Representative Director at Niigata Koyu Jigyo KK since 2004.
Prior to this, he worked as a Managing Director at Niigata Kotsu Co., Ltd.
Hideki Takeda is the founder of Scent Science International, Inc. He is currently an Independent Outside Director at Modalis Therapeutics Corp., a Representative Director at Medical Patent Research, Inc., an Outside Director at Ctex Co. Ltd., and a Director at Liid Pharmaceuticals, Inc. He received his undergraduate and graduate degrees from Osaka University.
Yutaka Takeda has worked as an Auditor at Onamba Co., Ltd.
since 2014.
Toru Takeda currently works at TV Asahi Corp.
(New), as Vice Chairman from 2019 and TV Asahi Holdings Corp., as Director from 2019.
No results for this search
- Stock Market
- Advanced search
- Norimasa Takeda